These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 3140465

  • 1. Study of intravesical mitomycin C in patients with multiple prior occurrences of superficial bladder cancer.
    Schwarzman MI, Johanson KE, Surya B, Brown J.
    Urology; 1988 Oct; 32(4):335-8. PubMed ID: 3140465
    [Abstract] [Full Text] [Related]

  • 2. Intravesical mitomycin C instillation as a prophylactic treatment of superficial bladder tumor.
    Kim HH, Lee C.
    J Urol; 1989 Jun; 141(6):1337-9; discussion 1339-40. PubMed ID: 2498532
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy of intravesical mitomycin C in the treatment of superficial transitional cell carcinoma of the urinary bladder.
    Pavlotsky A, Eidelman A, Barak F, Alon H, Horn Y.
    J Surg Oncol; 1989 May; 41(1):9-11. PubMed ID: 2497274
    [Abstract] [Full Text] [Related]

  • 5. Mitomycin-C and BCG in intravesical chemotherapy and immunotherapy of superficial bladder cancer. Finnbladder Research Group.
    Rintala E, Jauhiainen K, Alfthan O.
    Prog Clin Biol Res; 1989 May; 310():271-4. PubMed ID: 2505270
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Bladder wall calcification after intravesical mitomycin C treatment of superficial bladder cancer.
    Drago PC, Badalament RA, Lucas J, Drago JR.
    J Urol; 1989 Oct; 142(4):1071-2. PubMed ID: 2507794
    [Abstract] [Full Text] [Related]

  • 10. Re: Recurrence of superficial bladder carcinoma after intravesical instillation of Mitomycin-C.
    Parmar MK.
    Br J Urol; 1989 Dec; 64(6):659. PubMed ID: 2516758
    [No Abstract] [Full Text] [Related]

  • 11. Intravesical mitomycin C and superficial bladder tumors.
    Biserte J, Rigot JM, Mauroy B, Mazeman E.
    Prog Clin Biol Res; 1989 Dec; 303():411-5. PubMed ID: 2506555
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Is there an optimal treatment scheme for adjuvant intravesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitional carcinoma of the bladder.
    Kurth KH, Bouffioux C, Sylvester R, de Pauw M.
    Prog Clin Biol Res; 1988 Dec; 269():525-37. PubMed ID: 3134663
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. BCG-(RIVM) versus mitomycin intravesical therapy in patients with superficial bladder cancer. EORTC GU Group and the Dutch South-East Collaborative Group.
    Debruyne FM, van der Meijden AP, Franssen MP.
    Prog Clin Biol Res; 1989 Dec; 303():435-46. PubMed ID: 2506556
    [No Abstract] [Full Text] [Related]

  • 17. Use of intravesical cisplatin and mitomycin-C for recurrent transitional cell carcinoma of bladder refractory to thiotepa.
    Mobley WC, Loening SA, Narayana AS, Culp DA.
    Urology; 1986 Apr; 27(4):335-9. PubMed ID: 3083555
    [Abstract] [Full Text] [Related]

  • 18. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP, Witjes JA, Oosterhof GO, Debruyne MJ.
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [Abstract] [Full Text] [Related]

  • 19. BCG-RIVM versus BCG-Tice versus mitomycin-C in superficial bladder cancer. Rationale and design of the trial of the Southeast Co-operative Urological Group, The Netherlands.
    van der Meijden PM, Debruyne FM, Steerenberg PA, de Jong WH, Doesburg W.
    Prog Clin Biol Res; 1989 Feb; 310():285-98. PubMed ID: 2505272
    [No Abstract] [Full Text] [Related]

  • 20. Long-term observation after intravesical metaphylaxis with mitomycin C in patients with superficial bladder tumors.
    Maier U, Höbarth K.
    Urology; 1991 May; 37(5):481-2. PubMed ID: 1902606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.